The study, co-authored by William A. Ross, MD, associate professor of the department of gastroenterology, hepatology and nutrition at M.D. Anderson, and several colleagues, set out to assess the ability of PET-CT to detect colonic pathology by reviewing the records for patients who underwent PET/CT and colonoscopy at M.D. Anderson.
In a group of patients who had incidental colonic 18F-FDG activity on PET, 65 percent of patients had pathologic findings detected on colonoscopy that corresponded to the site of PET activity, according to an abstract of the study.
The authors conclude that incidental colonic activity detected by PET/CT merits further evaluation with colonoscopy. They noted that negative PET/CT results do not rule out significant colonic pathology.
Read the healthimaging.com article on PET/CT and colon cancer.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.